It promotes triglyceride level and adipose deposition within HepG2 cells, and induces diabetes‐associated metabolic diseases like insulin resistance and hyperglycemia by decreasing miR‐192‐5p and increasing its downstream TF FOXO1.233. Here, FOXO1 is linked to Insulin resistance.